All In Biotech

Drug Trial Radar · NCT06843239

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis

Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Feb 6, 2025

Primary completion

May 2027

Study completion Jan 2028

Sponsor

Lead sponsor
Zura Bio IncIndustry
Sponsor type
Industry
First posted
Feb 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 24 weeks (Period 1) in adult participants with systemic sclerosis, followed by an open-label extension period where all active participants will receive tibulizumab and will be evaluated for an additional 28 weeks (Period 2)

Conditions

  • Systemic Sclerosis (SSc)
  • Scleroderma

Interventions

  • TibulizumabBiological

    Anti BAFF/IL-17 antibody

  • PlaceboOther

    Placebo (inactive)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. [Period 1] Change from baseline in modified Rodnan Skin Score (mRSS) at 24 weeksTime frame: Week 24
  2. [Period 2] Safety and tolerability of tibulizumabTime frame: Week 52

Locations

60 sites in 10 countries. Site status is shown where the registry gives one.

  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research

    La Jolla, California

  • UCLA Department of Medicine

    Los Angeles, California

  • IRIS Research and Development LLC

    Plantation, Florida

  • University of Iowa

    Iowa City, Iowa

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan Hospital

    Ann Arbor, Michigan

  • Rheumatology Associates

    Arlington, Texas

  • Organización Médica de Investigación

    Buenos Aires, Argentina

  • Centro de Investigación y Prevención Cardiovascular-Arenales

    Buenos Aires, Argentina

  • Hospital General de Agudos Dr. José María Ramos Mejia

    Buenos Aires, Argentina

  • Instituto de Investigación Clínica TyT

    Buenos Aires, Argentina

  • Centro Medico de Estudios Clinicos y Farmacovigilancia (CECYF)

    Buenos Aires, Argentina

  • Consultorios Médicos Dr. Doreski

    Buenos Aires, Argentina

  • Consultora Integral de Salud Centro Médico Privado

    Córdoba, Argentina

  • Instituto CER S.A.

    Quilmes, Argentina

  • AES - AS - Clinica Mayo de Urgencias

    San Miguel de Tucumán, Argentina

  • STAT Research S.A.

    Buenos Aires, Buenos Aires, Argentina

  • Centro de Investigaciones Médicas Tucumán

    San Miguel de Tucumán, Tucumán Province, Argentina

  • CTR Estudios Clinicos

    Santiago, Chile

  • Enroll SpA

    Santiago, Chile

  • Centro de especialidades médicas Vanguardia

    Temuco, Chile

  • Clinical Research Chile SpA

    Valdivia, Chile

  • Centro de Estudios Clinicos Victoria Limitada (Cevic)

    Victoria, Chile

  • Dermacross Clinica Dermatologica

    Vitacura, Chile

  • Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus

    Debrecen, Hungary

  • Pécsi Tudomanyegyetem - Vasvari Pal u.

    Pécs, Hungary

  • Mediadvance Clinical

    Chihuahua City, Mexico

  • PanAmerican Clinical Research

    Guadalajara, Mexico

  • Medical Care and Research S.A. de C.V.

    Mérida, Mexico

  • Centro de Investigación y Tratamiento Reumatológico S.C

    Miguel Hidalgo, Mexico

  • Oaxaca Site Management Organization - Clinic - OSMO - PPDS

    Oaxaca City, Mexico

  • M2M Med-ul.

    Chorzów, Poland

  • Malopolskie Badania Kliniczne Sp. z o.o.

    Krakow, Poland

  • Malopolskie Centrum Kliniczne

    Krakow, Poland

  • Centrum Medyczne Plejady

    Krakow, Poland

  • Santa Familia PTG Łódź

    Lodz, Poland

  • Twoja Przychodnia NCM

    Nowa Sól, Poland

  • Twoja Przychodnia PCM - ul.

    Poznan, Poland

  • Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji

    Warsaw, Poland

  • Klinika Reuma Park sp . zoo Sp.k.

    Warsaw, Poland

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.